Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Inventory Average: 2012-2025

Historic Inventory Average for Adma Biologics (ADMA) over the last 8 years, with Sep 2025 value amounting to $194.1 million.

  • Adma Biologics' Inventory Average rose 10.39% to $194.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $194.1 million, marking a year-over-year increase of 10.39%. This contributed to the annual value of $171.6 million for FY2024, which is 2.07% up from last year.
  • As of Q3 2025, Adma Biologics' Inventory Average stood at $194.1 million, which was up 6.73% from $181.8 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Inventory Average registered a high of $194.1 million during Q3 2025, and its lowest value of $87.8 million during Q1 2021.
  • Over the past 3 years, Adma Biologics' median Inventory Average value was $171.2 million (recorded in 2025), while the average stood at $173.2 million.
  • In the last 5 years, Adma Biologics' Inventory Average surged by 89.77% in 2021 and then dropped by 2.34% in 2025.
  • Adma Biologics' Inventory Average (Quarterly) stood at $119.4 million in 2021, then spiked by 36.57% to $163.1 million in 2022, then increased by 3.01% to $168.0 million in 2023, then rose by 1.79% to $171.0 million in 2024, then rose by 10.39% to $194.1 million in 2025.
  • Its Inventory Average stands at $194.1 million for Q3 2025, versus $181.8 million for Q2 2025 and $171.2 million for Q1 2025.